UK markets open in 7 hours 26 minutes

Drägerwerk AG & Co. KGaA (DRW3.DE)

XETRA - XETRA Delayed price. Currency in EUR
Add to watchlist
72.00+1.00 (+1.41%)
At close: 5:35PM CEST
Full screen
Previous close71.00
Open71.40
Bid72.50 x 16300
Ask72.70 x 9400
Day's range70.90 - 72.70
52-week range40.18 - 108.50
Volume33,381
Avg. volume60,323
Market cap1.252B
Beta (5Y monthly)-0.37
PE ratio (TTM)14.44
EPS (TTM)4.99
Earnings dateN/A
Forward dividend & yield0.19 (0.27%)
Ex-dividend date01 Oct 2020
1y target est74.18
  • EQS Group

    Drägerwerk AG & Co. KGaA: Dräger agrees with the federal government to end the delivery of ventilators

    Drägerwerk AG & Co. KGaA / Key word(s): Agreement Drägerwerk AG & Co. KGaA: Dräger agrees with the federal government to end the delivery of ventilators 10-Sep-2020 / 16:28 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. * * *Ad-hoc notification in accordance with Sec. 17 of the MAR Drägerwerk AG & Co. KGaA: Dräger agrees with the federal government to end the delivery of ventilators In March, Dräger received a major order from the federal government for the delivery of 10,000 ventilators. Thereby, the federal government ensured sufficient supply for the health care system in Germany in times of great uncertainty due to COVID-19. Since the beginning of the pandemic, Dräger has been in close contact with the federal government and many other customers around the world. Considering the current status of the development of the pandemic in Germany and other countries, Dräger and the federal government have now agreed in principle that Dräger will not deliver any more devices to the federal government beyond the 1,557 already delivered. The federal government bears the costs incurred for providing and upholding the production capacity. The capacities that are now being freed up enable Dräger to supply other important markets outside Germany with ventilators that are still urgently needed there. Dräger's guidance published on July 14th remains unchanged. Accordingly, Dräger expects currency-adjusted net sales growth of 14 to 22 percent for 2020. The EBIT margin is expected to be between 7.0 and 11.0 percent.Drägerwerk AG & Co. KGaA Moislinger Allee 53-55 23558 Lübeck, Deutschland www.draeger.comInvestor Relations: Thomas Fischler Tel. +49 451 882-2685 thomas.fischler@draeger.comCorporate Communications: Melanie Kamann Tel. +49 451 882-3998 melanie.kamann@draeger.comDisclaimer This ad hoc report contains statements on the future development of Dräger Group. These forward-looking statements are based on the current expectations, presumptions, and forecasts of the Executive Board as well as the information available to date. They were compiled to the best of the company's knowledge. Dräger does not provide any warranty nor assume any responsibility for the future developments and results described above. These are dependent on a number of factors. They entail various risks and contingencies outside of the company's influence and are based on assumptions which could prove to be incorrect. Dräger does not assume any responsibility for updating the forward-looking statements contained in this report. This does not infringe any legal stipulations on the adjustment of forecasts. Please go to Investor Relations / Definitions of financial indicators at www.draeger.com for information on alternative performance measures used.* * *10-Sep-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de * * * Language: English Company: Drägerwerk AG & Co. KGaA Moislinger Allee 53-55 23542 Lübeck Germany Phone: +49 (0)451 882-0 Fax: +49 (0)451 882-2080 E-mail: info@draeger.com Internet: www.draeger.com ISIN: DE0005550602, DE 000 555 063 6, DE 000 555 065 1, DE 000 555 067 7, DE 000 555 071 9 WKN: 555060, 555063 Vorzüge, 555065 Genussschein A, 555067 Genussschein K, 555071 Genussschein D Indices: TecDAX Listed: Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime Standard), Hamburg, Hanover, Munich; Regulated Unofficial Market in Stuttgart, Tradegate Exchange EQS News ID: 1130085 End of Announcement DGAP News Service

  • EQS Group

    Drägerwerk AG & Co. KGaA: Dräger will expand capacity for mask production and will set up production in the United Kingdom to deliver respiratory masks to British government

    Drägerwerk AG & Co. KGaA / Key word(s): Incoming Orders Drägerwerk AG & Co. KGaA: Dräger will expand capacity for mask production and will set up production in the United Kingdom to deliver respiratory masks to British government 16-Jul-2020 / 14:49 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. * * *Ad-hoc notification in accordance with Sec. 17 of the MAR Drägerwerk AG & Co. KGaA: Dräger will expand capacity for mask production and will set up production in the United Kingdom to deliver respiratory masks to British governmentIn connection with the COVID 19 pandemic, Dräger has received an order from the British government to deliver respiratory masks (FFP3). The delivery of the order will start in 2020 and will stretch until end of 2021. The expected net sales are roughly one hundred million Euro. For this purpose Dräger will set up a mask production in the United Kingdom. This is in addition to the existing production network in Sweden and South Africa and the previously decided new production sites in France and the United States. The investment into the expansion across all five production sites in 2020 will be in the amount of a mid-double digit million Euro figure.Drägerwerk AG & Co. KGaA Moislinger Allee 53-55 23558 Lübeck, Deutschland www.draeger.comInvestor Relations: Thomas Fischler Tel. +49 451 882-2685 thomas.fischler@draeger.comCorporate Communications: Melanie Kamann Tel. +49 451 882-3998 melanie.kamann@draeger.comDisclaimer This ad hoc report contains statements on the future development of Dräger Group. These forward-looking statements are based on the current expectations, presumptions, and forecasts of the Executive Board as well as the information available to date. They were compiled to the best of the company's knowledge. Dräger does not provide any warranty nor assume any responsibility for the future developments and results described above. These are dependent on a number of factors. They entail various risks and contingencies outside of the company's influence and are based on assumptions which could prove to be incorrect. Dräger does not assume any responsibility for updating the forward-looking statements contained in this report. This does not infringe any legal stipulations on the adjustment of forecasts. Please go to Investor Relations / Definitions of financial indicators at www.draeger.com for information on alternative performance measures used.* * *16-Jul-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de * * * Language: English Company: Drägerwerk AG & Co. KGaA Moislinger Allee 53-55 23542 Lübeck Germany Phone: +49 (0)451 882-0 Fax: +49 (0)451 882-2080 E-mail: info@draeger.com Internet: www.draeger.com ISIN: DE0005550602, DE 000 555 063 6, DE 000 555 065 1, DE 000 555 067 7, DE 000 555 071 9 WKN: 555060, 555063 Vorzüge, 555065 Genussschein A, 555067 Genussschein K, 555071 Genussschein D Indices: TecDAX Listed: Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime Standard), Hamburg, Hanover, Munich; Regulated Unofficial Market in Stuttgart, Tradegate Exchange EQS News ID: 1095559 End of Announcement DGAP News Service

  • EQS Group

    Drägerwerk AG & Co. KGaA: preliminary result for the second quarter. Business development considerably above prior year.

    Drägerwerk AG & Co. KGaA / Key word(s): Preliminary Results Drägerwerk AG & Co. KGaA: preliminary result for the second quarter. Business development considerably above prior year. 14-Jul-2020 / 19:08 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. * * *In the context of the COVID-19 pandemic, Dräger's net sales and EBIT development are considerably above the prior year. Based on preliminary figures for the second quarter, Dräger recorded a year-on-year growth in order intake of 36.3 percent (net of currency effects; nominal: 33.6 percent). Net sales increased by 26.5 percent (net of currency effects; nominal: 24.3 percent) to around EUR 788.4 million (Q2 2019: EUR 634.3 million). EBIT for the second quarter stood at around EUR 102 million, considerably above the level of the prior year (Q2 2019: EUR -1.5 million). The higher earnings were caused by considerably higher net sales volume and a higher gross profit margin of around 49.2 percent (Q2 2019: 42.6 percent). In the first six months of 2020, order intake increased by 75.7 percent year-on-year (net of currency effects; nominal: 73.5 percent). Due to the COVID-19 pandemic, demand in the medical division was exceptionally strong. In the safety division, demand for light breathing protection (e.g. FFP masks) was considerably above the prior year. Group net sales increased by 17.1 percent (net of currency effects; nominal: 15.6 percent) to around EUR 1,428.4 million (6 months 2019: EUR 1,235.9 million). Total EBIT stood at approximately EUR 102 million (6 months 2019: EUR -12.2 million). Considering the high demand due to the COVID-19 pandemic, Dräger expects full year net sales and EBIT to be considerably above both the prior year and the original guidance. Dräger expects net sales growth for fiscal year 2020 to be between 14 percent and 22 percent (net of currency effects). The expectation for the EBIT margin is between 7.0 percent and 11.0 percent. Dräger will publish its full results for the first six months of the fiscal year on August 13, 2020. * * *14-Jul-2020 CET/CEST The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Archive at www.dgap.de * * * Language: English Company: Drägerwerk AG & Co. KGaA Moislinger Allee 53-55 23542 Lübeck Germany Phone: +49 (0)451 882-0 Fax: +49 (0)451 882-2080 E-mail: info@draeger.com Internet: www.draeger.com ISIN: DE0005550602, DE 000 555 063 6, DE 000 555 065 1, DE 000 555 067 7, DE 000 555 071 9 WKN: 555060, 555063 Vorzüge, 555065 Genussschein A, 555067 Genussschein K, 555071 Genussschein D Indices: TecDAX Listed: Regulated Market in Berlin, Dusseldorf, Frankfurt (Prime Standard), Hamburg, Hanover, Munich; Regulated Unofficial Market in Stuttgart, Tradegate Exchange EQS News ID: 1093659 End of Announcement DGAP News Service

By using Yahoo, you agree that we and our partners can use cookies for purposes such as customising content and advertising. See our Privacy Policy to learn more